MA53284A - Protéines de liaison à nkg2d, à cd16 et à un antigène associé à une tumeur - Google Patents

Protéines de liaison à nkg2d, à cd16 et à un antigène associé à une tumeur

Info

Publication number
MA53284A
MA53284A MA053284A MA53284A MA53284A MA 53284 A MA53284 A MA 53284A MA 053284 A MA053284 A MA 053284A MA 53284 A MA53284 A MA 53284A MA 53284 A MA53284 A MA 53284A
Authority
MA
Morocco
Prior art keywords
nkg2d
antigen binding
binding proteins
associated antigen
tumor associated
Prior art date
Application number
MA053284A
Other languages
English (en)
Inventor
Gregory P Chang
Ann F Cheung
Jinyan Du
Daniel Fallon
Asya Grinberg
William Haney
Bradley M Lunde
Steven O'neil
Bianka Prinz
Ronnie Wei
Original Assignee
Dragonfly Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dragonfly Therapeutics Inc filed Critical Dragonfly Therapeutics Inc
Publication of MA53284A publication Critical patent/MA53284A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA053284A 2018-08-08 2019-08-08 Protéines de liaison à nkg2d, à cd16 et à un antigène associé à une tumeur MA53284A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862716110P 2018-08-08 2018-08-08

Publications (1)

Publication Number Publication Date
MA53284A true MA53284A (fr) 2022-01-26

Family

ID=69415105

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053284A MA53284A (fr) 2018-08-08 2019-08-08 Protéines de liaison à nkg2d, à cd16 et à un antigène associé à une tumeur

Country Status (13)

Country Link
US (1) US20220153848A1 (fr)
EP (1) EP3833385A4 (fr)
JP (1) JP7482363B2 (fr)
KR (1) KR20210078473A (fr)
CN (1) CN113164570B (fr)
AU (1) AU2019318087A1 (fr)
BR (1) BR112021002276A2 (fr)
CA (1) CA3108646A1 (fr)
IL (1) IL280618A (fr)
MA (1) MA53284A (fr)
MX (1) MX2021001527A (fr)
SG (1) SG11202101298XA (fr)
WO (1) WO2020033664A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019218136A1 (en) 2018-02-08 2020-08-13 Dragonfly Therapeutics, Inc. Antibody variable domains targeting the NKG2D receptor
MX2024007317A (es) * 2021-12-16 2024-06-26 Univ Basel Variantes discernibles de proteina de superficie celular de cd117 para usarse en terapia celular.
WO2024008910A1 (fr) 2022-07-07 2024-01-11 Cimeio Therapeutics Ag Anticorps ciblant cd117

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074439A1 (es) * 2008-12-02 2011-01-19 Pf Medicament Anticuerpo anti-cmet (receptor c-met)
US8545839B2 (en) * 2008-12-02 2013-10-01 Pierre Fabre Medicament Anti-c-Met antibody
TW201109438A (en) * 2009-07-29 2011-03-16 Abbott Lab Dual variable domain immunoglobulins and uses thereof
UY33492A (es) * 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
EP2710042A2 (fr) * 2011-05-16 2014-03-26 Fabion Pharmaceuticals, Inc. Protéines de fusion contenant un fab multi-spécifique et procédé d'utilisation
GB201203442D0 (en) * 2012-02-28 2012-04-11 Univ Birmingham Immunotherapeutic molecules and uses
GB2519786A (en) * 2013-10-30 2015-05-06 Sergej Michailovic Kiprijanov Multivalent antigen-binding protein molecules
CN106471117A (zh) * 2014-05-06 2017-03-01 豪夫迈·罗氏有限公司 使用哺乳动物细胞产生异多聚体蛋白
JP6744313B2 (ja) * 2015-01-02 2020-08-26 ダイアックス コーポレーション 血漿カリクレインおよび第ｘｉｉ因子に対する二重特異性抗体
CA2990511A1 (fr) * 2015-06-23 2016-12-29 Innate Pharma Proteines qui se lient a des antigenes multispecifiques
EP3374389A1 (fr) * 2015-11-13 2018-09-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Anticorps à domaine unique anti-nkg2d et utilisations de ceux-ci
WO2017165464A1 (fr) * 2016-03-21 2017-09-28 Elstar Therapeutics, Inc. Molécules multispécifiques et multifonctionnelles et leurs utilisations
KR20200118824A (ko) * 2018-02-08 2020-10-16 드래곤플라이 쎄라퓨틱스, 인크. 자연 살해 세포를 활성화시키는 다중-특이성 결합 단백질을 수반하는 암의 병용 요법

Also Published As

Publication number Publication date
MX2021001527A (es) 2021-06-15
JP7482363B2 (ja) 2024-05-14
CN113164570A (zh) 2021-07-23
AU2019318087A1 (en) 2021-03-04
US20220153848A1 (en) 2022-05-19
JP2021533159A (ja) 2021-12-02
BR112021002276A2 (pt) 2021-05-04
CN113164570B (zh) 2024-05-14
EP3833385A4 (fr) 2021-12-22
WO2020033664A1 (fr) 2020-02-13
EP3833385A1 (fr) 2021-06-16
IL280618A (en) 2021-03-25
SG11202101298XA (en) 2021-03-30
KR20210078473A (ko) 2021-06-28
CA3108646A1 (fr) 2020-02-13

Similar Documents

Publication Publication Date Title
IL280673A (en) Proteins that bind nkg2d, cd16, and tumor-associated antigen
MX2024000742A (es) Anticuerpos anti-tigit.
MA54513A (fr) Molécules de liaison à l'antigène cd28 agonistes de ciblage de tumeurs
MA50255A (fr) Protéines de liaison à nkg2d, cd16, et molécule-1 semblable à la lectine de type c (cll-1)
IL281323A (en) Proteins that bind D2NKG, 16CD, and tumor-associated antigen
MA47465A (fr) Protéines fixant le bcma, le nkg2d et le cd16
EP3773676A4 (fr) Protéines de liaison à nkg2d, cd16 et à un antigène associé à des tumeurs, des mdsc et/ou des tam
DK3582806T5 (da) Proteiner, der binder her2, nkg2d og cd16
MA47508A (fr) Protéines de liaison à cd33, nkg2d et cd16
MA42821A (fr) Protéines de liaison à l'antigène tétraspécifiques et bispécifiques tétravalentes et utilisations de celles-ci
MA53284A (fr) Protéines de liaison à nkg2d, à cd16 et à un antigène associé à une tumeur
IL272706A (en) Proteins that bind D2NKG, 16CD, and tumor-associated antigen
IL270803A (en) NKG2D, CD16 and tumor-associated antigen binding protein
IL280656A (en) Multispecific binding proteins that bind HER2, NKG2D, and CD16 and methods of use
EA202091350A1 (ru) Связывающие молекулы, специфично связывающиеся с тау-белком
GB201802338D0 (en) Antigen binding proteins
IL270801A (en) NKG2D, CD16 and tumor-associated antigen binding protein
EA201992281A1 (ru) Связывающие молекулы, специфично связывающиеся с тау-белком
MX2021008216A (es) Anticuerpos anti-tigit.
MA46844A (fr) Protéines de liaison à un antigène anti-gitr et leurs procédés d'utilisation
IL268574A (en) proteins that bind psma, nkg2d, and cd16
MA53094A (fr) Protéine de liaison à l'antigène anti-steap1
IL268768A (en) Proteins binding gd2, nkg2d and cd16
EP3689894A4 (fr) Protéine de liaison à l'immunoglobuline, et support d'affinité mettant en uvre celle-ci
EP3583132A4 (fr) Protéines de liaison à cd123, nkg2d et cd16